Spinal Stimulation in Chronic Spinal Cord Injury

Sponsor
The Neurokinex Charitable Trust (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04132596
Collaborator
International Spinal Research Trust (Other)
12
2
3
23.7
6
0.3

Study Details

Study Description

Brief Summary

Electrical spinal stimulation combined with activity-based rehabilitation (ABR) can improve motor and autonomic function in individuals suffering from varying degrees of paralysis. Spinal stimulation studies have included invasive implanted devices and non-invasive transcutaneous systems using different combinations of stimulation current, waveform, amplitude, duration and spinal levels targeted. Invasive and non-invasive systems have been demonstrated to permit individuals with chronic spinal cord injury (SCI), previously considered to have complete injuries on the International Standards for the Neurological Classification of Spinal Cord Injuries (ISNCSCI) scale (Classification A), to regain some degree of voluntary and autonomic function during periods of stimulation. The aim of this study is to evaluate the effects of a novel non-invasive transcutaneous electrical spinal cord stimulation system (tSCS) combined with activity-based rehabilitation in patients who have paralysis of their legs and/or arms. We will examine participants for any changes in sensory, motor or autonomic function. We will use a transcutaneous spinal cord stimulator that has been designed to deliver safe and tolerable bursts of high frequency pulsed current that minimise the capacitance efforts of the skin surface and maximise conductance of a second waveform using low frequency current to target neural structures. We aim to investigate this form of neuromodulation with a small group of individuals with chronic spinal cord injury. Our goal is to observe and describe any short term or lasting changes in function that can safely and comfortably be derived from this combination of spinal stimulation and activity-based rehabilitation. If this therapy can cause lasting improvements in sensory, motor, respiratory or autonomic function, then this may lead to a greater degree of functional independence for these individuals.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcutaneous spinal cord stimulation
  • Other: Activity Based Therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Cohort studyCohort study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Non-invasive Spinal Cord Stimulation Combined With Activity-based Rehabilitation in Chronic Spinal Cord Injury
Actual Study Start Date :
Nov 11, 2019
Anticipated Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Motor Complete Tetraplegia

C4-T1 American Spinal Injuries Association (ASIA) Impairment Scale Classification A or B spinal cord injury tscs with activity based therapy intervention

Device: Transcutaneous spinal cord stimulation
Electrical stimulation of the spinal cord via transcutaneous hydrogel electrodes

Other: Activity Based Therapy
Physical therapy

Experimental: Motor Complete Paraplegia

T2-12 ASIA Impairment Scale A or B spinal cord injury tscs with activity based therapy intervention

Device: Transcutaneous spinal cord stimulation
Electrical stimulation of the spinal cord via transcutaneous hydrogel electrodes

Other: Activity Based Therapy
Physical therapy

Experimental: Motor incomplete SCI

C4-T12 ASIA Impairment Scale C or D spinal cord injury tscs with activity based therapy intervention

Device: Transcutaneous spinal cord stimulation
Electrical stimulation of the spinal cord via transcutaneous hydrogel electrodes

Other: Activity Based Therapy
Physical therapy

Outcome Measures

Primary Outcome Measures

  1. International Standards for the Neurological Classification of Spinal Cord Injury Classification scores (ISNCSCI ASIA chart) [1 year]

    Sensory and motor scores. Sensory scale 0-224, motor scale 0-100 with higher scores relating to increased sensation and motor power

  2. Spinal Cord Independence Measure (SCIM) [1 year]

    Functional independence tool for spinal cord injury. Scale of 0-100, with higher scores meaning increased function

  3. Berg Balance Score (where applicable) [1 year]

    Measure of standing balance. Scale of 0-56, with higher values meaning increased standing balance and reduced risk of falls

  4. NeuroRecovery Scale (NRS) [1 year]

    Functional independence measure rated from 1a, the lowest classification of functioning to 4C, the highest classification of functioning

  5. Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Test [1 year]

    Upper limb measure of sensation and function. Strength scored 0-100, sensation scored 0-24 and prehension scored 0-64. Increased score relates to increased hand strength, sensation and function

  6. Capabilities of Upper Extremity Questionnaire (CUE) [1 year]

    Upper limb capability questionnaire with 32 items. Scores between 32-124 with higher scores associated with higher levels of function of the upper limb

  7. Force dynamometry - hand [1 year]

    Grip and pinch strength using JTech force transducers. Measurements taken in Newtons

  8. Electromyography (EMG) of muscle activity [1 year]

    Upper limb, trunk and lower limb EMG using the Delsys Trigno System

Secondary Outcome Measures

  1. World Health Organisation Quality Of Life - BREF (WHOQOL-BREF) [1 year]

    Quality of Life self report questionnaire with 26 items, subdivided into Physical Health (raw score range 7-35), Psychological Health (raw score range 6-30), Social Relationships (raw score range 3-15), Environment (raw score range 8-40)

  2. International Spinal Cord Society Autonomic Standards Assessment Form [1 year]

    Bladder function questionnaire to document method of bladder management

  3. International Spinal Cord Society Autonomic Standards Assessment Form [1 year]

    Bowel function questionnaire to document method of bowel management

  4. International Spinal Cord Society Autonomic Standards Assessment Form [1 year]

    Cardiovascular function questionnaire to document ability to regulate cardiovascular system

  5. International Spinal Cord Society Autonomic Standards Assessment Form [1 year]

    Sexual function questionnaire to document symptoms and impairments resulting from spinal cord injury

  6. Modified Ashworth Scale [1 year]

    Spasticity measure, scores of 0 - no increase in spasticity to 4 - affected part rigid

  7. Respiratory function tests of maximal inspiratory and expiratory pressures [1 year]

    Maximal inspiratory and expiratory pressures in breathing,

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participant is willing and able to give informed consent for participation in the study

  • Aged 18 years or over

  • Injury level C4-T12

  • At least one year post spinal cord injury

  • Medically stable and cognitively intact

  • Independent respiration, not requiring any ventilatory support

Exclusion Criteria:
  • Any active implanted metallic device including, but not limited to neurostimulators, cochlear implants, pacemakers, implantable defibrillators or drug delivery pump

  • Implanted surgical hardware that is not compatible with MRI scanners

  • Possible, suspected or confirmed pregnancy and/or lactation

  • Active Heterotopic Ossification

  • Recent history or fracture, contractures or pressure sore, deep vein thrombosis or urinary tract or other infection that may interfere with the intervention and training.

  • History of epilepsy and/or seizures.

  • Severe spasticity which have been unstable over the past 3 months prior to enrolment and not expected to change; taking varying doses of anti-spasticity medications which could not be tapered to a stable dose and is not expected to change

  • Botulinum toxin injections within 6 months of participation (excluding bladder)

  • Non-injury related neurological impairment

  • Clinically significant severe depression in spite of treatment

  • Patients who have cardiovascular disease

  • Patients with Autonomic Dysreflexia that is severe, ongoing and has required medical treatment within the past one month

  • Active aggressive tumour within or surrounding the spinal cord or brain stem

  • A syrinx (fluid filled cavity) in the spinal cord

  • Skin conditions or allergies that may affect electrode placement

  • Bodyweight over 120kg (due to inability to use some of the study equipment)

  • Patients who do not understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neurokinex Gatwick United Kingdom RH10 9NE
2 Neurokinex Hemel Hempstead United Kingdom HP2 7BW

Sponsors and Collaborators

  • The Neurokinex Charitable Trust
  • International Spinal Research Trust

Investigators

  • Principal Investigator: Jane Symonds, Physio, Clinical Lead Physiotherapist

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
The Neurokinex Charitable Trust
ClinicalTrials.gov Identifier:
NCT04132596
Other Study ID Numbers:
  • Pathfinder 2.0
First Posted:
Oct 21, 2019
Last Update Posted:
Sep 16, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020